Pharmaceutical industry innovation and developments /
I tiakina i:
| Kaituhi rangatōpū: | |
|---|---|
| Ētahi atu kaituhi: | , |
| Hōputu: | Tāhiko īPukapuka |
| Reo: | Ingarihi |
| I whakaputaina: |
Hauppauge, N.Y. :
Nova Science,
c2011.
|
| Rangatū: | Business issues, competition and entrepreneurship series.
Pharmacology-research, safety testing, and regulation series. |
| Ngā marau: | |
| Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite
Pharmaceutical industry innovation and developments /
I whakaputaina: (2011)
I whakaputaina: (2011)
The agile approach to adaptive research optimizing efficiency in clinical development /
mā: Rosenberg, Michael J.
I whakaputaina: (2010)
mā: Rosenberg, Michael J.
I whakaputaina: (2010)
The agile approach to adaptive research optimizing efficiency in clinical development /
mā: Rosenberg, Michael J.
I whakaputaina: (2010)
mā: Rosenberg, Michael J.
I whakaputaina: (2010)
Applications of microdialysis in pharmaceutical science
I whakaputaina: (2011)
I whakaputaina: (2011)
Applications of microdialysis in pharmaceutical science
I whakaputaina: (2011)
I whakaputaina: (2011)
Quality assurance of pharmaceuticals a compendium of guidelines and related materials. Volume 2, Good manufacturing practices and inspection.
I whakaputaina: (2007)
I whakaputaina: (2007)
Quality assurance of pharmaceuticals a compendium of guidelines and related materials. Volume 2, Good manufacturing practices and inspection.
I whakaputaina: (2007)
I whakaputaina: (2007)
Outsourcing clinical development strategies for working with CROs and other partners /
I whakaputaina: (2006)
I whakaputaina: (2006)
Outsourcing clinical development strategies for working with CROs and other partners /
I whakaputaina: (2006)
I whakaputaina: (2006)
ADME-enabling technologies for drug design and development
I whakaputaina: (2012)
I whakaputaina: (2012)
ADME-enabling technologies for drug design and development
I whakaputaina: (2012)
I whakaputaina: (2012)
Therapeutic targets modulation, inhibition, and activation /
I whakaputaina: (2012)
I whakaputaina: (2012)
Therapeutic targets modulation, inhibition, and activation /
I whakaputaina: (2012)
I whakaputaina: (2012)
Drugs : from discovery to approval /
mā: Ng, Rick
I whakaputaina: (2015)
mā: Ng, Rick
I whakaputaina: (2015)
Drugs : from discovery to approval /
mā: Ng, Rick
I whakaputaina: (2015)
mā: Ng, Rick
I whakaputaina: (2015)
Drug discovery practices, processes, and perspectives /
I whakaputaina: (2013)
I whakaputaina: (2013)
Drug discovery practices, processes, and perspectives /
I whakaputaina: (2013)
I whakaputaina: (2013)
Predictive approaches in drug discovery and development biomarkers and in vitro/in vivo correlations /
I whakaputaina: (2012)
I whakaputaina: (2012)
Predictive approaches in drug discovery and development biomarkers and in vitro/in vivo correlations /
I whakaputaina: (2012)
I whakaputaina: (2012)
Drug discovery and design medical aspects /
I whakaputaina: (2002)
I whakaputaina: (2002)
Drug discovery and design medical aspects /
I whakaputaina: (2002)
I whakaputaina: (2002)
Regulating pharmaceuticals in Europe striving for efficiency, equity and quality /
I whakaputaina: (2004)
I whakaputaina: (2004)
Regulating pharmaceuticals in Europe striving for efficiency, equity and quality /
I whakaputaina: (2004)
I whakaputaina: (2004)
WHO Expert Committee on Specification for Pharmaceutical Preparations forty-second report.
I whakaputaina: (2008)
I whakaputaina: (2008)
WHO Expert Committee on Specification for Pharmaceutical Preparations forty-second report.
I whakaputaina: (2008)
I whakaputaina: (2008)
Physiological pharmaceutics barriers to drug absorption /
mā: Washington, Neena, 1961-
I whakaputaina: (2001)
mā: Washington, Neena, 1961-
I whakaputaina: (2001)
Physiological pharmaceutics barriers to drug absorption /
mā: Washington, Neena, 1961-
I whakaputaina: (2001)
mā: Washington, Neena, 1961-
I whakaputaina: (2001)
Pharmaceutical blending and mixing /
I whakaputaina: (2015)
I whakaputaina: (2015)
Pharmaceutical blending and mixing /
I whakaputaina: (2015)
I whakaputaina: (2015)
Human drug targets : a compendium for pharmaceutical discovery /
mā: Zanders, Edward D.
I whakaputaina: (2016)
mā: Zanders, Edward D.
I whakaputaina: (2016)
Human drug targets : a compendium for pharmaceutical discovery /
mā: Zanders, Edward D.
I whakaputaina: (2016)
mā: Zanders, Edward D.
I whakaputaina: (2016)
Innovation and the pharmaceutical industry critical reflections on the virtues of profit /
I whakaputaina: (2008)
I whakaputaina: (2008)
Innovation and the pharmaceutical industry critical reflections on the virtues of profit /
I whakaputaina: (2008)
I whakaputaina: (2008)
Evaluation of drug candidates for preclinical development pharmacokinetics, metabolism, pharmaceutics, and toxicology /
I whakaputaina: (2010)
I whakaputaina: (2010)
Evaluation of drug candidates for preclinical development pharmacokinetics, metabolism, pharmaceutics, and toxicology /
I whakaputaina: (2010)
I whakaputaina: (2010)
Development of therapeutic agents handbook
I whakaputaina: (2012)
I whakaputaina: (2012)
Development of therapeutic agents handbook
I whakaputaina: (2012)
I whakaputaina: (2012)
Manufacturing of pharmaceutical proteins : from technology to economy /
mā: Behme, Stefan
I whakaputaina: (2015)
mā: Behme, Stefan
I whakaputaina: (2015)
Manufacturing of pharmaceutical proteins : from technology to economy /
mā: Behme, Stefan
I whakaputaina: (2015)
mā: Behme, Stefan
I whakaputaina: (2015)
A mathematical approach to multilevel, multiscale health interventions pharmaceutical industry decline and policy response /
mā: Wallace, Rodrick
I whakaputaina: (2013)
mā: Wallace, Rodrick
I whakaputaina: (2013)